NCT06786169Recruiting
The Relationship of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer
Cohort Studies of Associations of Psychological Stress With Therapy Efficacy and Prognosis of Gastric Cancer (G-STRESS)
Source: ClinicalTrials.gov · Last updated 22 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is the prospective, observational cohort study (G-Distress) to explore the associations of psychological stress with treatment and prognosis of gastric cancer. The participants including the patients diagnosed with gastric cancer who received surgery, chemotherapy and immune checkpoint inhibitors.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 5 Sept 2024
- Start date
- 5 Sept 2024
- Primary completion date
- 15 Sept 2026
- Lead sponsor
- Fudan University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06786169
What you commit to
- Study type: Observational
- Planned participants: 600
- From 5 Sept 2024 to the primary completion date, 15 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Unavailable for R0 resection and D2 lymph node dissection.
- Unavailable for chemotherapy, radiotherapy, immunotherapy or target therapy
- Unavailable for chemotherapy, radiotherapy, immunotherapy or target therapy
Other illness
- History of chemotherapy, radiotherapy, immunotherapy or target therapy
- Suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, complicated by poorly controlled hypertension, diabetes, mental disorders or diseases
- Patients with stage IV gastric cancer
- Cohort 2
- Suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, complicated by poorly controlled hypertension, diabetes, mental disorders or diseases
- Suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, complicated by poorly controlled hypertension, diabetes, mental disorders or diseases
Other
- Multiple primary tumors
- Multiple primary tumors
- Unavailable for gastrectomy
- Cohort 2
- Multiple primary tumors
Who the study is looking for
- Lower age limit of research subjects 18 years old and upper age limit of 80 years old, ECOG (ECOG score standard) performance status of 0 or 1
- Be proven to be primary adenocarcinoma of gastric cancer and staged II-III by pathological evidences
- R0 gastrectomy with D2 lymphadenectomy
- Receiving adjuvant chemotherapy
- Lower age limit of research subjects 18 years old and upper age limit of 80 years old, ECOG (ECOG score standard) performance status of 0 or 1
- Be proven to be primary adenocarcinoma of gastric cancer and staged III-IV by pathological evidences
- Receiving gastrectomy
- Receiving preoperative chemotherapy
- Lower age limit of research subjects 18 years old and upper age limit of 80 years old, ECOG (ECOG score standard) performance status of 0 or 1
- Be proven to be primary adenocarcinoma of gastric cancer and staged IV by pathological evidences
- Unavailable for gastrectomy
- Presence of at least one measurable lesion according to the Response Evaluation Criteria in Solid Tumors version 1.1
Criteria the registry did not label
- Cohort 1
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.